CD Skripsi
Perbandingan Kadar C-Reactive Protein Pasien Covid-19 Yang Survive Dan Nonsurvive Di Rumah Sakit Umum Daerah Arifin Achmad Provinsi Riau
ABSTRACT
COMPARISON OF C-REACTIVE PROTEIN LEVELS OF COVID-19 PATIENTS WHO SURVIVE AND NONSURVIVE AT ARIFIN ACHMAD REGIONAL GENERAL HOSPITAL, RIAU PROVINCE
By:
Aurellia Najmi
Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Coronavirus Disease 2019 (COVID-19) is a health emergency due to its high infection and fatality rates. Therefore, effective clinical management is necessary. The use of relevant prognostic indicators can assist clinical management in identifying patients at risk of disease worsening, one of which is C-Reactive Protein (CRP). C-Reactive Protein (CRP) is a protein marker of acute phase inflammation. This study compared the CRP levels of COVID-19 patients who survive and nonsurvive. The design of this study was cross-sectional with a total sample of 90 medical records of COVID-19 patients treated at Arifin Achmad Hospital, Riau Province. The results of this study showed the characteristics of patients, most of whom are women (57.8%) and most of whom are 46-59 years old (31.1%). C-Reactive Protein (CRP) levels of surviving patients were in the range of 0.3-114.3 mg/L with a median of 8.3 mg/L while nonsurviving patients were in the range of 11.8-515.1 mg/L with a median of 109.9 mg/L. Statistically, there was a significant difference in CRP levels between surviving and nonsurviving COVID-19 patients (p
Tidak tersedia versi lain